What is unique to iLead

  • We have a pan-African approach to innovation and problem solving across the laboratory value chain.
  • We have a Strong Social Responsibility and commitment and reside in Africa
  • We work in environments that:
    • have high burdens of both communicable and non-communicable diseases
    • where populations have inequitable access to healthcare
    • where Africa’s science and technology systems are grossly underdeveloped as a result of underinvestment in R&D and poor implementation policies due to lack of human and institutional capacity
    • where the laboratory and laboratory-clinic interface are frequently neglected
    • growing Young populations: 60% <25 year (South Africa)
    • good research not translated into Intellectual Property for sustainability
  • Our approach is agile and flexible to accommodate often unstable political climates
  • Our team is multidisciplinary with clinicians, scientists, biomedical engineers, implementation specialists, health economists (HE) and specialists in big data analytics
  • We have vast experience in implementation science and successfully manage/have managed large national laboratory programs that deliver complex services in the public sector from centralized to very decentralized settings
  • Regional Implementation programs that drive needs based research
  • Our laboratories encompass routine services within national programs, R&D and high level clinical and diagnostic trials across disease types and extend within our own networks and partners with a good understanding of evaluations beyond technology
  • We have a well-established biorepository
  • Our laboratory processes can be scaled and are underpinned by quality systems focused on pre-analytical, analytical and post analytical systems
  • We have success in developing our own solutions (concept to global impact) to address local needs with global impact
  • Well connected and contribute to global policies
  • We understand the regulatory and statutory frameworks in Africa
  • Our operating costs are relatively lower than Europe and the US
  • We remain within the academic realm with a direct impact on future curricula, new talent and capacity building